LUNG — Pulmonx Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1127537 ·
Last close
$2.73
Market Cap
$119.11M
52W High
$3.25
52W Low
$1.13
ADV30
994,967
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 22,756,000 | 17,742,000 | -9,057,000 | -10,080,000 | 114,732,000 | 55,843,000 | 75,536,000 |
| Mar 2026 | 20,586,000 | 16,044,000 | -12,956,000 | -13,654,000 | 119,966,000 | 61,572,000 | 74,205,000 |
| Dec 2025 | 22,598,000 | 17,541,000 | -9,903,000 | -10,425,000 | 129,291,000 | 69,751,000 | 75,175,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-25,578,000
Investing CF
$-31,000
Financing CF
$1,729,000
CapEx
$-31,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.01
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-553,686,000
Inventory
$15,436,000
Receivables
$12,526,000
ST Investments
$0
EBIT TTM
$-37,736,000
Pretax Income TTM
$-41,934,000
Interest Exp TTM
$4,198,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$88,775,000
EBITDA
$-38,409,000
Free Cash Flow
$-11,744,750
Enterprise Value
$114,188,896
Total Cash
$52,690,000
Total Debt
$56,346,000
Shares Out
43,550,665
Trailing EPS
$-1.01
Book Value
$0.79
ROE
-90.3%
ROA
-19.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 90,497,000 | -53,663,000 | -54,003,000 | 129,291,000 | 75,175,000 | 54,116,000 | -32,376,000 |
| Dec 2024 | 83,789,000 | -57,704,000 | -56,394,000 | 162,850,000 | 77,041,000 | 85,809,000 | -31,537,000 |
| Dec 2023 | 68,675,000 | -61,935,000 | -60,843,000 | 177,781,000 | 59,466,000 | 118,315,000 | -37,610,000 |
| Dec 2022 | 53,662,000 | -58,637,000 | -58,923,000 | 193,676,000 | 39,669,000 | 154,007,000 | -45,083,000 |
TTM Snapshot
Revenues TTM
$87,442,000
NetIncome TTM
$-48,116,000
OpCashFlow TTM
—
Assets (Latest)
$114,732,000
Forward EPS
$-0.92
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $2.69 · call volume: 43 · put volume: 76
Expected Move to 2027-02-19:
±$1.02
(38.10%) —
implied range
$1.67 –
$3.72
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APYX | Apyx Medical Corp | $107.63M | $2.56 | — |
| PYPD | PolyPid Ltd. | $132.84M | $6.54 | — |
| FOCL | EDAP TMS SA | $134.10M | $2.84 | — |
| TLSI | TriSalus Life Sciences, Inc. | $141.60M | $2.30 | — |
| STIM | Neuronetics, Inc. | $99.49M | $1.28 | — |
News headlines (Yahoo Finance, 1h cache)
Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-18 21:05 · Yahoo
Pulmonx Announces Publication of CONVERT Trial Results for AeriSeal® System
2026-11-17 12:10 · Yahoo
Pulmonx: 3 Key Takeaways for Long-Term Investors
2026-11-08 23:35 · Yahoo
All You Need to Know About Pulmonx (LUNG) Rating Upgrade to Buy
2026-10-30 15:00 · Yahoo
Pulmonx to Participate in Upcoming Investor Conferences
2026-10-28 20:05 · Yahoo
Pulmonx (LUNG) Q3 2026 Earnings Call Transcript
2026-10-27 23:43 · Yahoo
What Pulmonx (LUNG) Said on Its Q3 Earnings Call
2026-10-27 23:04 · Yahoo
Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates
2026-10-27 21:20 · Yahoo
Pulmonx Reports Third Quarter 2026 Financial Results
2026-10-27 20:05 · Yahoo
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
2026-10-13 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.